AMPA Receptors
AMPA receptors are members of the ionotropic class of glutamate receptors, which also includes NMDA and Kainate receptors. AMPA receptors mediate fast excitatory synaptic transmission and play a role in hippocampal synaptic long-term potentiation and depression.
AMPA Receptor Agonists |
|
---|---|
Cat. No. | Product Name / Activity |
1074 | (RS)-AMPA hydrobromide |
Selective AMPA agonist; more water soluble form of (RS)-AMPA (Cat. No. 0169) | |
0169 | (RS)-AMPA |
Selective AMPA agonist | |
0254 | (S)-AMPA |
Selective AMPA agonist; active isomer of (RS)-AMPA (Cat. No. 0169) | |
0188 | L-Quisqualic acid |
AMPA agonist; also group I mGlu agonist | |
AMPA Receptor Antagonists |
|
Cat. No. | Product Name / Activity |
0190 | CNQX |
Potent and selective non-NMDA iGluR antagonist | |
1045 | CNQX disodium salt |
Potent non-NMDA iGluR antagonist; more water soluble form of CNQX (Cat. No. 0190) | |
2932 | CP 465022 hydrochloride |
Selective and non-competitive AMPA antagonist | |
0189 | DNQX |
Selective non-NMDA iGluR antagonist | |
2312 | DNQX disodium salt |
Selective non-NMDA iGluR antagonist; water-soluble salt of DNQX (Cat. No. 0189) | |
0845 | Evans Blue tetrasodium salt |
Non-NMDA iGluR antagonist; P2X antagonist; also inhibits L-glutamate uptake into synaptic vesicles | |
1454 | GYKI 52466 dihydrochloride |
Selective non-competitive AMPA antagonist | |
2555 | GYKI 53655 hydrochloride |
Non-competitive non-NMDA iGluR antagonist | |
4198 | IEM 1925 dihydrobromide |
Voltage- and use-dependent open-channel AMPA blocker | |
2766 | Naspm trihydrochloride |
Ca2+-permeable AMPA antagonist | |
0373 | NBQX |
Potent AMPA antagonist; more selective than CNQX (Cat. No. 0190) | |
1044 | NBQX disodium salt |
Potent AMPA antagonist; more water soluble form of NBQX (Cat. No. 0373) | |
5032 | Talampanel |
Non-competitive non-NMDA iGluR antagonist | |
2345 | ZK 200775 |
Competitive non-NMDA iGluR antagonist | |
AMPA Receptor Modulators |
|
Cat. No. | Product Name / Activity |
2980 | CX 546 |
AMPA potentiator | |
5149 | CX 614 |
Positive allosteric modulator of AMPA receptors | |
0713 | Cyclothiazide |
Positive allosteric modulator of AMPA receptors; inhibits AMPA desensitization | |
6278 | JNJ 55511118 |
High affinity and selective negative modulator of AMPA receptors containing TARP-γ8 | |
5297 | LY 404187 |
Selective positive allosteric modulator of AMPA receptors | |
6353 | UoS 12258 |
Positive allosteric modulator of AMPA receptors | |
AMPA Receptor Blockers |
|
Cat. No. | Product Name / Activity |
1636 | IEM 1460 |
Open-channel blocker of AMPA currents; selective for non-GluA2-containing receptors | |
Other |
|
Cat. No. | Product Name / Activity |
0964 | Diazoxide |
Inhibits AMPA desensitization | |
6094 | 2R,6R-Hydroxynorketamine hydrochloride |
Ketamine metabolite; enhances AMPA currents; lacks ketamine-related side effects | |
6095 | 2S,6S-Hydroxynorketamine hydrochloride |
Ketamine metabolite; decreases D-serine (a NMDA co-agonist); antidepressant | |
5982 | cis-6-Hydroxynorketamine hydrochloride |
Metabolite of ketamine (Cat.No. 3131); enhances AMPA currents |
AMPA receptors are cation-permeable, ligand-gated ion channels. Like other members of this family, AMPA receptors are named based on a compound that was found to be selective for these receptors; α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA). They consist of GluA1-4 subunits that assemble as homomers or heteromers to form functional receptors. Each subunit is encoded by a different gene, and alternative versions of the subunits may be produced by gene splicing. There is a large heterogeneity within the exact subunit conformation of endogenous AMPA receptors, with brain region specific expression seen for some splice variants.
The subunit composition of an AMPA receptor determines its physiological properties, in particular the extent to which these ion channels are permeable to Ca2+. Calcium permeability can be traced to a single amino acid residue within the re-entrant loop of subunit GluA2, termed the Q/R site. In GluA1, A3 and A4 subunits a glutamine (Q) is found at this site, however in the GluA2 subunit an arginine (R) is present, due to post-translation modification. AMPA receptors containing a GluA2 subunit are relatively impermeable to Ca2+, while receptors lacking this subunit are highly Ca2+ permeable. This site also regulates single channel conductance of AMPA receptors, and their sensitivity to some toxins.
AMPA receptors play a key role in synaptic plasticity, particularly in long-term potentiation (LTP), which is thought to be the cellular correlate of learning and memory. LTP describes an increase in excitatory postsynaptic potential (EPSP) size, which starts when glutamate binds to postsynaptic AMPA and NMDA receptors. Activation of AMPA receptors by ligand binding leads to opening of the pore and enables Na+ influx into the postsynaptic neuron causing depolarization. Once depolarization is strong enough to displace Mg2+ ions from the ion pore of NMDA receptors, these receptors allow more Na+ and Ca2+ to enter the cell. Entry of Ca2+ results in upregulation of trafficking of AMPA receptors to the membrane, through a CaMKII - Ras - MAPK signaling pathway. Phosphorylation of CaMKII caused by the rise in intracellular Ca2+ in turn phosphorylates AMPA receptors, increasing their single channel conductance.
External sources of pharmacological information for AMPA Receptors :
Literature for AMPA Receptors
Tocris offers the following scientific literature for AMPA Receptors to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Addiction Poster
The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
Parkinson's Disease Poster
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.
AMPA Receptor Gene Data
Gene | Species | Gene Symbol | Gene Accession No. | Protein Accession No. |
---|---|---|---|---|
GluA1 | Human | GRIA1 | NM_000827 | P42261 |
Mouse | Gria1 | NM_008165 | P23818 | |
Rat | Gria1 | NM_031608 | P19490 | |
GluA2 | Human | GRIA2 | NM_001083620 | Q12879 |
Mouse | Gria2 | NM_013540 | P23819 | |
Rat | Gria2 | NM_017261 | P19491 | |
GluA3 | Human | GRIA3 | NM_000828 | P42263 |
Mouse | Gria3 | NM_016886 | Q9Z2W9 | |
Rat | Gria3 | NM_032990 | P19492 | |
GluA4 | Human | GRIA4 | NM_001077243 | P48058 |
Mouse | Gria4 | NM_019691 | Q9Z2W8 | |
Rat | gria4 | NM_017263 | P19493 |